Abstract
Diabetic euglycaemic ketoacidosis is a possible adverse effect of sodium-glucose co-transporter-2 inhibitors (SGLT2i). We report a case in which the combination of SGLT2i and a strict very low-carbohydrate diet led to severe diabetic ketoacidosis in a young Caucasian man with type 2 diabetes.
Keywords:
diabetes; diet; drugs: endocrine system; endocrine system; unwanted effects/adverse reaction.
© BMJ Publishing Group Limited 2019. No commercial re-use. See rights and permissions. Published by BMJ.
MeSH terms
-
Adult
-
Blood Glucose / drug effects
-
Diabetes Mellitus, Type 2 / metabolism*
-
Diabetes Mellitus, Type 2 / physiopathology
-
Diabetes Mellitus, Type 2 / therapy
-
Diabetic Ketoacidosis / diagnosis*
-
Diabetic Ketoacidosis / etiology
-
Diabetic Ketoacidosis / physiopathology
-
Diabetic Ketoacidosis / therapy
-
Diet, Carbohydrate-Restricted / adverse effects*
-
Diet, Reducing / adverse effects
-
Diet, Reducing / methods*
-
Directive Counseling
-
Humans
-
Hypoglycemic Agents / therapeutic use*
-
Male
-
Obesity / physiopathology
-
Obesity / therapy*
-
Sodium-Glucose Transporter 2 Inhibitors / adverse effects*
-
Sodium-Glucose Transporter 2 Inhibitors / therapeutic use
-
Treatment Outcome
Substances
-
Blood Glucose
-
Hypoglycemic Agents
-
Sodium-Glucose Transporter 2 Inhibitors